Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-31
1999-11-23
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514342, 514369, 514370, 514372, 514374, 514376, 514377, 514378, 514380, 5462697, 5462711, 5462721, 5462724, 5462804, 5462834, 5462754, 548182, 548183, 548184, 548186, 548187, 548189, 548190, 548191, A61K 3144, C07D41314
Patent
active
059901357
ABSTRACT:
A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
REFERENCES:
Sham, H. L., et al., "Facile Synthesis of Potent HIV-1 Protease Inhibitors containing a Novel Pseudo-symmetric Dipeptide Isotere", Journal of the Chemical Society, 13:1052-1053 (1993).
Kempf Dale J.
Norbeck Daniel W.
Sham Hing Leung
Zhao Chen
Abbott Laboratories
Crowley Steven R.
Davis Zinna Northington
Ward Michael J.
LandOfFree
Retroviral protease inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral protease inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibiting compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222331